N-butyldeoxygalactonojirimycin reduces postnatal cerebellar ganglioside content in a mouse model of GM1 gangliosidosis

Samankaltaisia teoksia

• N-butyldeoxygalactonojirimycin reduces neonatal brain ganglioside content in a mouse model of GM1 gangliosidosis.
  Tekijä: Kasperzyk, J, et al.
  Julkaistu: (2004)
• "Substrate reduction reduces gangliosides in postnatal cerebrum-brainstem and cerebellum in GM1 gangliosidosis mice" (vol 46, pg 744, 2004)
  Tekijä: Kasperzyk, J, et al.
  Julkaistu: (2005)
• N-butyldeoxygalactonojirimycin reduces brain ganglioside and GM2 content in neonatal Sandhoff disease mice.
  Tekijä: Baek, R, et al.
  Julkaistu: (2008)
• N-butyldeoxygalactonojirimycin reduces brain ganglioside and GM2 content in neonatal sandhoff diseased mice
  Tekijä: Baek, R, et al.
  Julkaistu: (2004)
• Erratum: Substrate reduction reduces gangliosides in postnatal cerebrum-brainstem and cerebellum in GM1 gangliosidosis mice (Journal of Lipid Research (April 2004) 46 (744-751))
  Tekijä: Kasperzyk, J, et al.
  Julkaistu: (2005)